----
Q3 FY2024 Earnings
Financial report interval: 2024.06.30 - 2024.09.30
Overview: Aadi Biosciences(AADI) the Revenue is 7.212 M (+21.03%);the EBIT is -10.78 M (+39.63%);the EPS is -0.464 (+23.31%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.01B21.03%
----
----
EBIT
-0.01B39.63%
----
----
EPS
-0.46423.31%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf
